Akari Therapeutics, Plc
AKTX
$1.21
$0.1059.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.72% | -46.23% | 218.85% | -65.93% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -76.77% | -50.81% | -34.55% | 311.37% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 183.70% | -2.13% | -59.48% | 17.77% | -- |
| Total Current Assets | 7.97% | -46.14% | 83.12% | -36.14% | -- |
|
|
|||||
| Total Current Assets | 7.97% | -46.14% | 83.12% | -36.14% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1,749.38% | -46.14% | 83.12% | -36.35% | -- |
|
|
|||||
| Total Accounts Payable | 159.45% | 2.05% | 46.07% | 91.98% | -- |
| Total Accrued Expenses | 20.42% | 54.60% | 10.13% | -2.30% | -- |
| Short-term Debt | 226.00% | 0.00% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 6.24% | -26.07% | -11.28% | 17.82% | -- |
| Total Other Current Liabilities | 6.24% | -26.07% | -11.28% | 17.82% | -- |
| Total Current Liabilities | 111.18% | 7.39% | 38.80% | 37.98% | -- |
|
|
|||||
| Total Current Liabilities | 111.18% | 7.39% | 38.80% | 37.98% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 226.00% | 0.00% | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 200.52% | 7.39% | 38.80% | 37.98% | -- |
|
|
|||||
| Common Stock & APIC | 17.52% | 0.04% | 4.15% | 1.11% | -- |
| Retained Earnings | -1.55% | -1.20% | -3.24% | -2.45% | -- |
| Treasury Stock & Other | 0.37% | -0.34% | 0.02% | 0.55% | -- |
| Total Common Equity | 432.07% | -80.77% | -4.22% | -1,451.53% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 432.07% | -80.77% | -4.22% | -1,451.53% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 432.07% | -80.77% | -4.22% | -1,451.53% | -- |
|
|
|||||